Regulations.gov document
Potential Medication Error Risks With Investigational Drug Container Labels; Public…
Notice · FDA-2021-N-0127 · posted Mar 16, 2021
Key facts
| Document ID | FDA-2021-N-0127-0001 |
|---|---|
| Title | Potential Medication Error Risks With Investigational Drug Container Labels; Public Meeting; Request for Comments |
| Document type | Notice |
| Subtype | Request for Comments |
| Agency | FDA |
| Docket | FDA-2021-N-0127 |
| Posted | Mar 16, 2021 |
| Federal Register citation | 86 FR 14457 |
| FR document number | 2021-05370 |
| Comment period opens | Mar 16, 2021 |
| Comments due | Jun 19, 2021 |
| Effective date | Mar 16, 2021 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: